These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

The combination of cyclopentolate hydrochloride 0.2% and phenylephrine hydrochloride 1% (Cyclomydril ®) is desirable for mydriasis prior to examining premature infants because it delivers lower ...

FDA experts report changes in drug approvals, warnings, and indications for products for use by dermatologists and aesthetic medicine professionals.

Compr Ophthalmol Update. 2005;6(2):85-101. Systemic corticosteroids are used in the treatment of severe inflammatory conditions of the eye, such as posterior uveitis or scleritis. Systemic ...

After hours: 7:58:21 p.m. EST ...

The company’s current commercial portfolio includes clobetasol propionate ophthalmic suspension, 0.05%, for post-surgical pain and inflammation, and Mydcombi® for mydriasis. For more information, ...